Voglihop-M

Voglihop-M 0.2 Tablet ER is used to control high blood sugar in people with type 2 diabetes, especially when diet, exercise, and a single diabetes medicine are not enough. It helps lower blood sugar levels and prevents complications from diabetes, such as kidney damage and nerve problems.

Voglihop-M 0.2 Tablet ER alone rarely causes low blood sugar. However, when combined with other diabetes medicines, such as insulin or sulfonylureas, it can cause hypoglycemia. Watch out for signs such as dizziness, sweating, and shaking, and carry a sugary snack if at risk.

Individuals should avoid taking Voglihop-M 0.2 Tablet ER if they have severe kidney problems, liver disease, heart failure, serious infections, or alcoholism. It is also not suitable if they are allergic to metformin, voglibose, or any ingredient present in Voglihop-M 0.2 Tablet ER.

In elderly people, kidney function may decline with age. Since metformin (present in Voglihop-M 0.2 Tablet ER) can affect the kidneys, doctors will check kidney function (GFR) regularly and adjust the dose accordingly.

Voglihop-M 0.2 Tablet ER is not safe if kidney function is severely reduced (GFR below 30 mL/min). For mild to moderate kidney issues, the doctor may adjust the dose of this medicine and check kidney function regularly.

Though rare, Voglihop-M 0.2 Tablet ER may cause lactic acidosis, a serious condition with symptoms such as muscle pain, breathing difficulty, and weakness. If you feel unwell suddenly, seek emergency medical help.

No, do not stop taking Voglihop-M 0.2 Tablet ER, or other diabetes medicines without a doctor’s advice. Even if sugar levels are normal, stopping the medicine may cause blood sugar to rise again.